What the Trained Eye Cannot See: Detecting Movement Defects in Early Stage Parkinson's Disease Aug. 15, 2024 — Using machine learning to analyze video recordings of individuals performing simple ...

Recent scientific discoveries are challenging traditional views of Parkinson’s disease, suggesting that this neurological condition might actually begin in an unexpected place, the digestive system.

A paper on the biomarker, published in the journal Lancet Neurology, found that αSyn-SAA was 87% accurate at detecting early-stage Parkinson’s disease in a cross-sectional analysis of 1,123 ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Shares of Prothena climbed Thursday after the company said a trial of its Parkinson's treatment suggests potential clinical benefits in the early stages of the disease, even though it missed its ...

treatment with tavapadon as a monotherapy in adults with early Parkinson's disease. Also Read: Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

While this research is still in its early stages, it represents something valuable: hope. For the millions of people affected by Parkinson’s disease worldwide, every new discovery is a step ...

What the Trained Eye Cannot See: Detecting Movement Defects in Early Stage Parkinson's Disease Aug. 15, 2024 — Using machine learning to analyze video recordings of individuals performing simple ...